Mads Agerbæk

12PUBLICATIONS
60CO-AUTHORS
Radiation therapyPredictive and prognostic markersLiquid biopsiesRecommender systemsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 25, 2025
Clinical implementation of intensity modulated proton therapy for testicular seminoma.

Heidi S Rønde, Jesper F Kallehauge, Morten Høyer

|Aug 07, 2025
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial.

Matthew D Galsky, Dean F Bajorin, Yoshihiko Tomita

|Apr 15, 2025
Circulating tumour DNA and circulating tumour cells in bladder cancer - from discovery to clinical implementation.

Sia V Lindskrog, Trine Strandgaard, Iver Nordentoft

|Oct 11, 2024
Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274.

Matthew D Galsky, Johannes Alfred Witjes, Jürgen E Gschwend

|Oct 02, 2023
Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up.

Sia V Lindskrog, Karin Birkenkamp-Demtröder, Iver Nordentoft

|Sep 08, 2023
Prognostic Factors for Relapse in Patients With Clinical Stage I Testicular Seminoma: A Nationwide, Population-Based Cohort Study.

Thomas Wagner, Birgitte Grønkær Toft, Jakob Lauritsen

Pageof 2

Frequent Collaborators

5 joint publications

Lars Dyrskjøt

4 joint publications

Emil Christensen

4 joint publications

Philippe Lamy

4 joint publications

Iver Nordentoft